6.65
전일 마감가:
$6.60
열려 있는:
$6.72
하루 거래량:
55,897
Relative Volume:
0.57
시가총액:
$182.42M
수익:
$21.25M
순이익/손실:
$-16.05M
주가수익비율:
-10.90
EPS:
-0.61
순현금흐름:
$-17.14M
1주 성능:
-0.45%
1개월 성능:
+15.85%
6개월 성능:
+18.12%
1년 성능:
-25.11%
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
명칭
Fennec Pharmaceuticals Inc
전화
(919) 636-4530
주소
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
FENC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
FENC
Fennec Pharmaceuticals Inc
|
6.65 | 182.42M | 21.25M | -16.05M | -17.14M | -0.61 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2022-11-22 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2022-09-07 | 개시 | CapitalOne | Overweight |
2022-08-08 | 재개 | Craig Hallum | Buy |
2020-06-05 | 개시 | Cantor Fitzgerald | Overweight |
2018-10-11 | 개시 | Goldman | Buy |
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Chris Anigeron Rallis Sells 1,186 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - MarketBeat
(FRX) Proactive Strategies (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Above 50-Day Moving AverageHere's Why - MarketBeat
Fennec Pharmaceuticals director sells shares worth $8,088 By Investing.com - Investing.com Nigeria
Fennec Pharmaceuticals director sells shares worth $8,088 - Investing.com India
(FENC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells 10,000 Shares of Stock - MarketBeat
Rostislav Christov Raykov Sells 2,431 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - MarketBeat
Fennec Pharmaceuticals Inc. - MENAFN.COM
Norgine introduces PEDMARQSI in Germany for pediatric cancer care - MSN
Stocks In Play: Fennec Pharmaceuticals Inc. By Baystreet.ca - Investing.com Canada
Fennec Pharmaceuticals director Raykov sells $66,600 in shares - MSN
Fennec Pharmaceuticals Announces Commercial Launch of Pedmarqsi in Germany - Marketscreener.com
Fennec Pharmaceuticals' Pedmarqsi Launched in Germany by Norgine Pharmaceuticals - Marketscreener.com
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany - The Manila Times
Fennec Pharmaceuticals Brief: Announcing Commercial Launch of PEDMARQSI In Germany - Marketscreener.com
Revolutionary Cancer Drug PEDMARQSI Now Available in Germany$273M Deal Potential - StockTitan
Insider Sell Alert: Rosty Raykov Sells 10,000 Shares of Fennec P - GuruFocus.com
Fennec Pharmaceuticals director Raykov sells $66,600 in shares By Investing.com - Investing.com South Africa
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Sees Large Decrease in Short Interest - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Above 50-Day Moving AverageHere's What Happened - MarketBeat
Trend Tracker for (FENC) - Stock Traders Daily
Fennec PharmaA Sound Investment? - RTTNews
Fennec Pharmaceuticals (NASDAQ:FENC) shareholder returns have been respectable, earning 41% in 3 years - Simply Wall St
Fennec Pharmaceuticals (NASDAQ:FENC) versus CARGO Therapeutics (NASDAQ:CRGX) Financial Survey - Defense World
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Barclays PLC Raises Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Learn to Evaluate (FENC) using the Charts - Stock Traders Daily
Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$87,552.00 in Stock - MarketBeat
Barclays PLC Grows Position in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stock - MarketBeat
Fennec Pharmaceuticals director Raykov Rosty sells $60,800 in shares By Investing.com - Investing.com Australia
Fennec Pharmaceuticals director Raykov Rosty sells $60,800 in shares - Investing.com
Franklin Resources Inc. Has $74,000 Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
State Street Corp Has $1.64 Million Stake in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals (TSE:FRX) Shares Pass Above 50 Day Moving AverageShould You Sell? - MarketBeat
Stocks In Play: Fennec Pharmaceuticals Inc. - Barchart
(FENC) Trading Advice - Stock Traders Daily
Fennec Pharmaceuticals Inc (FENC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fennec Pharmaceuticals Inc 주식 (FENC) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
RALLIS CHRIS A | Director |
Feb 14 '25 |
Sale |
6.82 |
1,186 |
8,089 |
53,020 |
자본화:
|
볼륨(24시간):